Picard Medical FY2025 revenue up 12.5% to $4.9M, net loss widens to $27.0M

Picard Medical, Inc.

Revenue $4.94M (+12.5% YoY); product revenue $4.75M, 96% of total.
Gross margin negative 4.1% vs -2.6% in 2024; gross loss $(0.2)M.
Operating loss $(13.3)M, slightly improved from $(13.7)M; net loss $(27.0)M vs $(21.1)M.
Cash & equivalents $11.5M at year-end vs $0.1M in 2024; raised $17.4M net from equity and $9.7M net from debt in 2025.
Company expects to continue investing; additional capital needed to support operations.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Picard Medical, Inc. reported the year ended December 31, 2025 results: revenue $4.94 million, net income $(27.0) million.

Period: the year ended December 31, 2025
Revenue: $4.94 million
Net income: $(27.0) million
Result: reported results

Exact text from the filing

be available shortly after the call on the Company’s website, picardmedical.com, and continue to be available for 60 days. Financial Results Revenue Total revenue for 2025 was $4.94 million, compared to $4.39 million in 2024, representing an increase of 12.5 percent. Product revenue was $4.75 million, while rental revenue was $0.19 million. Product revenue was

View on SEC.gov

168 earnings releases filed in the last 30 days. Browse all earnings releases →

Picard Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001829126-26-002663

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.